nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ESR1—liver cancer	0.49	0.692	CbGaD
Estropipate—ALB—liver cancer	0.218	0.308	CbGaD
Estropipate—CYP1A2—Sorafenib—liver cancer	0.00899	0.365	CbGbCtD
Estropipate—CYP2C9—Sorafenib—liver cancer	0.0081	0.328	CbGbCtD
Estropipate—CYP3A4—Sorafenib—liver cancer	0.00471	0.191	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—liver cancer	0.00286	0.116	CbGbCtD
Estropipate—Quinestrol—ESR1—liver cancer	0.00121	0.192	CrCbGaD
Estropipate—Mestranol—ESR1—liver cancer	0.000917	0.146	CrCbGaD
Estropipate—Estriol—ESR1—liver cancer	0.0008	0.127	CrCbGaD
Estropipate—Cyst—Epirubicin—liver cancer	0.000779	0.00543	CcSEcCtD
Estropipate—Acute coronary syndrome—Sorafenib—liver cancer	0.000777	0.00541	CcSEcCtD
Estropipate—Neuropathy peripheral—Sorafenib—liver cancer	0.000773	0.00538	CcSEcCtD
Estropipate—Myocardial infarction—Sorafenib—liver cancer	0.000773	0.00538	CcSEcCtD
Estropipate—Embolism—Doxorubicin—liver cancer	0.000751	0.00523	CcSEcCtD
Estropipate—Hypercalcaemia—Epirubicin—liver cancer	0.00075	0.00522	CcSEcCtD
Estropipate—Hepatobiliary disease—Sorafenib—liver cancer	0.000746	0.00519	CcSEcCtD
Estropipate—Estramustine—ESR1—liver cancer	0.000744	0.118	CrCbGaD
Estropipate—Thrombosis—Epirubicin—liver cancer	0.000736	0.00513	CcSEcCtD
Estropipate—Blister—Epirubicin—liver cancer	0.000723	0.00503	CcSEcCtD
Estropipate—Cyst—Doxorubicin—liver cancer	0.000721	0.00502	CcSEcCtD
Estropipate—Vaginal haemorrhage—Epirubicin—liver cancer	0.000704	0.0049	CcSEcCtD
Estropipate—Neuritis—Epirubicin—liver cancer	0.000698	0.00486	CcSEcCtD
Estropipate—Hypercalcaemia—Doxorubicin—liver cancer	0.000694	0.00483	CcSEcCtD
Estropipate—Thrombosis—Doxorubicin—liver cancer	0.000681	0.00474	CcSEcCtD
Estropipate—Erythema multiforme—Sorafenib—liver cancer	0.000669	0.00466	CcSEcCtD
Estropipate—Blister—Doxorubicin—liver cancer	0.000669	0.00466	CcSEcCtD
Estropipate—Cardiac disorder—Sorafenib—liver cancer	0.000657	0.00458	CcSEcCtD
Estropipate—Vaginal haemorrhage—Doxorubicin—liver cancer	0.000651	0.00454	CcSEcCtD
Estropipate—Neuritis—Doxorubicin—liver cancer	0.000646	0.0045	CcSEcCtD
Estropipate—Angiopathy—Sorafenib—liver cancer	0.000642	0.00447	CcSEcCtD
Estropipate—Immune system disorder—Sorafenib—liver cancer	0.000639	0.00445	CcSEcCtD
Estropipate—Mediastinal disorder—Sorafenib—liver cancer	0.000638	0.00444	CcSEcCtD
Estropipate—Alopecia—Sorafenib—liver cancer	0.000626	0.00436	CcSEcCtD
Estropipate—Mental disorder—Sorafenib—liver cancer	0.00062	0.00432	CcSEcCtD
Estropipate—Erythema—Sorafenib—liver cancer	0.000616	0.00429	CcSEcCtD
Estropipate—Malnutrition—Sorafenib—liver cancer	0.000616	0.00429	CcSEcCtD
Estropipate—Neoplasm malignant—Epirubicin—liver cancer	0.00061	0.00425	CcSEcCtD
Estropipate—Breast pain—Epirubicin—liver cancer	0.000597	0.00416	CcSEcCtD
Estropipate—Jaundice cholestatic—Epirubicin—liver cancer	0.000593	0.00413	CcSEcCtD
Estropipate—Cardiovascular disorder—Epirubicin—liver cancer	0.000593	0.00413	CcSEcCtD
Estropipate—Amenorrhoea—Epirubicin—liver cancer	0.000593	0.00413	CcSEcCtD
Estropipate—Muscle spasms—Sorafenib—liver cancer	0.000592	0.00413	CcSEcCtD
Estropipate—Bone disorder—Epirubicin—liver cancer	0.000577	0.00402	CcSEcCtD
Estropipate—Hypocalcaemia—Epirubicin—liver cancer	0.000569	0.00396	CcSEcCtD
Estropipate—Cough increased—Epirubicin—liver cancer	0.000569	0.00396	CcSEcCtD
Estropipate—Neoplasm malignant—Doxorubicin—liver cancer	0.000564	0.00393	CcSEcCtD
Estropipate—Angioedema—Sorafenib—liver cancer	0.000563	0.00392	CcSEcCtD
Estropipate—Breast pain—Doxorubicin—liver cancer	0.000552	0.00385	CcSEcCtD
Estropipate—Amenorrhoea—Doxorubicin—liver cancer	0.000549	0.00382	CcSEcCtD
Estropipate—Cardiovascular disorder—Doxorubicin—liver cancer	0.000549	0.00382	CcSEcCtD
Estropipate—Jaundice cholestatic—Doxorubicin—liver cancer	0.000549	0.00382	CcSEcCtD
Estropipate—Cough—Sorafenib—liver cancer	0.000538	0.00375	CcSEcCtD
Estropipate—Inflammation—Epirubicin—liver cancer	0.000537	0.00374	CcSEcCtD
Estropipate—Bone disorder—Doxorubicin—liver cancer	0.000534	0.00372	CcSEcCtD
Estropipate—Musculoskeletal pain—Epirubicin—liver cancer	0.000527	0.00367	CcSEcCtD
Estropipate—Cough increased—Doxorubicin—liver cancer	0.000527	0.00367	CcSEcCtD
Estropipate—Hypocalcaemia—Doxorubicin—liver cancer	0.000527	0.00367	CcSEcCtD
Estropipate—Myalgia—Sorafenib—liver cancer	0.000525	0.00365	CcSEcCtD
Estropipate—Arthralgia—Sorafenib—liver cancer	0.000525	0.00365	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000521	0.00363	CcSEcCtD
Estropipate—Vaginal inflammation—Epirubicin—liver cancer	0.000521	0.00363	CcSEcCtD
Estropipate—Pulmonary embolism—Epirubicin—liver cancer	0.000521	0.00363	CcSEcCtD
Estropipate—Cystitis noninfective—Epirubicin—liver cancer	0.000509	0.00354	CcSEcCtD
Estropipate—Cystitis—Epirubicin—liver cancer	0.000503	0.0035	CcSEcCtD
Estropipate—Anaphylactic shock—Sorafenib—liver cancer	0.000503	0.0035	CcSEcCtD
Estropipate—Infection—Sorafenib—liver cancer	0.0005	0.00348	CcSEcCtD
Estropipate—Inflammation—Doxorubicin—liver cancer	0.000497	0.00346	CcSEcCtD
Estropipate—Fluid retention—Epirubicin—liver cancer	0.000495	0.00345	CcSEcCtD
Estropipate—Nervous system disorder—Sorafenib—liver cancer	0.000493	0.00344	CcSEcCtD
Estropipate—Vaginal infection—Epirubicin—liver cancer	0.000492	0.00343	CcSEcCtD
Estropipate—Skin disorder—Sorafenib—liver cancer	0.000488	0.0034	CcSEcCtD
Estropipate—Musculoskeletal pain—Doxorubicin—liver cancer	0.000488	0.0034	CcSEcCtD
Estropipate—Vaginal inflammation—Doxorubicin—liver cancer	0.000482	0.00336	CcSEcCtD
Estropipate—Pulmonary embolism—Doxorubicin—liver cancer	0.000482	0.00336	CcSEcCtD
Estropipate—Cramps of lower extremities—Epirubicin—liver cancer	0.000479	0.00333	CcSEcCtD
Estropipate—Neoplasm—Epirubicin—liver cancer	0.000471	0.00328	CcSEcCtD
Estropipate—Bladder pain—Epirubicin—liver cancer	0.000471	0.00328	CcSEcCtD
Estropipate—Cystitis noninfective—Doxorubicin—liver cancer	0.000471	0.00328	CcSEcCtD
Estropipate—Cystitis—Doxorubicin—liver cancer	0.000465	0.00324	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000458	0.00319	CcSEcCtD
Estropipate—Fluid retention—Doxorubicin—liver cancer	0.000458	0.00319	CcSEcCtD
Estropipate—Hypertonia—Epirubicin—liver cancer	0.000457	0.00318	CcSEcCtD
Estropipate—Vaginal infection—Doxorubicin—liver cancer	0.000455	0.00317	CcSEcCtD
Estropipate—Cramps of lower extremities—Doxorubicin—liver cancer	0.000443	0.00308	CcSEcCtD
Estropipate—Dyspepsia—Sorafenib—liver cancer	0.000443	0.00308	CcSEcCtD
Estropipate—Ethinyl Estradiol—ESR1—liver cancer	0.000437	0.0694	CrCbGaD
Estropipate—Thrombophlebitis—Epirubicin—liver cancer	0.000437	0.00304	CcSEcCtD
Estropipate—Neoplasm—Doxorubicin—liver cancer	0.000436	0.00304	CcSEcCtD
Estropipate—Bladder pain—Doxorubicin—liver cancer	0.000436	0.00304	CcSEcCtD
Estropipate—Gastrointestinal disorder—Sorafenib—liver cancer	0.000434	0.00302	CcSEcCtD
Estropipate—Fatigue—Sorafenib—liver cancer	0.000434	0.00302	CcSEcCtD
Estropipate—Hepatic function abnormal—Epirubicin—liver cancer	0.000433	0.00301	CcSEcCtD
Estropipate—Constipation—Sorafenib—liver cancer	0.00043	0.003	CcSEcCtD
Estropipate—Pain—Sorafenib—liver cancer	0.00043	0.003	CcSEcCtD
Estropipate—Hypertonia—Doxorubicin—liver cancer	0.000423	0.00294	CcSEcCtD
Estropipate—Gastrointestinal pain—Sorafenib—liver cancer	0.000411	0.00286	CcSEcCtD
Estropipate—Thrombophlebitis—Doxorubicin—liver cancer	0.000404	0.00282	CcSEcCtD
Estropipate—Hepatic function abnormal—Doxorubicin—liver cancer	0.0004	0.00279	CcSEcCtD
Estropipate—Urticaria—Sorafenib—liver cancer	0.0004	0.00278	CcSEcCtD
Estropipate—Abdominal pain—Sorafenib—liver cancer	0.000398	0.00277	CcSEcCtD
Estropipate—Body temperature increased—Sorafenib—liver cancer	0.000398	0.00277	CcSEcCtD
Estropipate—Dermatitis bullous—Epirubicin—liver cancer	0.000396	0.00276	CcSEcCtD
Estropipate—Purpura—Epirubicin—liver cancer	0.000392	0.00273	CcSEcCtD
Estropipate—Anaphylactoid reaction—Epirubicin—liver cancer	0.000391	0.00272	CcSEcCtD
Estropipate—Cerebrovascular accident—Epirubicin—liver cancer	0.000386	0.00269	CcSEcCtD
Estropipate—Conjugated Estrogens—ESR1—liver cancer	0.000382	0.0606	CrCbGaD
Estropipate—Estrone—ESR1—liver cancer	0.000381	0.0604	CrCbGaD
Estropipate—Pain in extremity—Epirubicin—liver cancer	0.000378	0.00263	CcSEcCtD
Estropipate—Migraine—Epirubicin—liver cancer	0.000372	0.00259	CcSEcCtD
Estropipate—Hypersensitivity—Sorafenib—liver cancer	0.000371	0.00258	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—liver cancer	0.000366	0.00255	CcSEcCtD
Estropipate—Purpura—Doxorubicin—liver cancer	0.000363	0.00253	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000362	0.00252	CcSEcCtD
Estropipate—Asthenia—Sorafenib—liver cancer	0.000361	0.00251	CcSEcCtD
Estropipate—Mood swings—Epirubicin—liver cancer	0.000358	0.0025	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—liver cancer	0.000357	0.00249	CcSEcCtD
Estropipate—Pruritus—Sorafenib—liver cancer	0.000356	0.00248	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—liver cancer	0.00035	0.00244	CcSEcCtD
Estropipate—Migraine—Doxorubicin—liver cancer	0.000344	0.0024	CcSEcCtD
Estropipate—Diarrhoea—Sorafenib—liver cancer	0.000344	0.0024	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—liver cancer	0.000342	0.00238	CcSEcCtD
Estropipate—Dizziness—Sorafenib—liver cancer	0.000333	0.00232	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—liver cancer	0.000331	0.00231	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—liver cancer	0.000329	0.00229	CcSEcCtD
Estropipate—Asthma—Epirubicin—liver cancer	0.000327	0.00228	CcSEcCtD
Estropipate—Influenza—Epirubicin—liver cancer	0.000327	0.00228	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—liver cancer	0.00032	0.00223	CcSEcCtD
Estropipate—Vomiting—Sorafenib—liver cancer	0.00032	0.00223	CcSEcCtD
Estropipate—Rash—Sorafenib—liver cancer	0.000317	0.00221	CcSEcCtD
Estropipate—Dermatitis—Sorafenib—liver cancer	0.000317	0.00221	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—liver cancer	0.000316	0.0022	CcSEcCtD
Estropipate—Headache—Sorafenib—liver cancer	0.000315	0.00219	CcSEcCtD
Estropipate—Estrone—CYP2E1—liver cancer	0.000309	0.049	CrCbGaD
Estropipate—Dysuria—Epirubicin—liver cancer	0.000306	0.00213	CcSEcCtD
Estropipate—Estrone—CYP1A1—liver cancer	0.000304	0.0483	CrCbGaD
Estropipate—Abdominal distension—Doxorubicin—liver cancer	0.000304	0.00212	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—liver cancer	0.000304	0.00212	CcSEcCtD
Estropipate—Asthma—Doxorubicin—liver cancer	0.000302	0.00211	CcSEcCtD
Estropipate—Influenza—Doxorubicin—liver cancer	0.000302	0.00211	CcSEcCtD
Estropipate—Nausea—Sorafenib—liver cancer	0.000299	0.00208	CcSEcCtD
Estropipate—Weight increased—Epirubicin—liver cancer	0.000297	0.00207	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—liver cancer	0.000296	0.00207	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—liver cancer	0.000295	0.00205	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—liver cancer	0.000291	0.00203	CcSEcCtD
Estropipate—Infestation—Epirubicin—liver cancer	0.000291	0.00203	CcSEcCtD
Estropipate—Estradiol—ESR1—liver cancer	0.000289	0.0458	CrCbGaD
Estropipate—Neuropathy peripheral—Epirubicin—liver cancer	0.000286	0.00199	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—liver cancer	0.000283	0.00197	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000281	0.00196	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—liver cancer	0.000276	0.00192	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—liver cancer	0.000275	0.00192	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—liver cancer	0.000273	0.0019	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—liver cancer	0.000273	0.0019	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—liver cancer	0.00027	0.00188	CcSEcCtD
Estropipate—Infestation—Doxorubicin—liver cancer	0.00027	0.00188	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—liver cancer	0.000264	0.00184	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—liver cancer	0.000262	0.00183	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—liver cancer	0.00026	0.00181	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—liver cancer	0.000258	0.0018	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—liver cancer	0.000255	0.00178	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—liver cancer	0.000253	0.00176	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—liver cancer	0.000252	0.00176	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—liver cancer	0.000247	0.00172	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—liver cancer	0.000244	0.0017	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—liver cancer	0.000243	0.00169	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—liver cancer	0.000243	0.00169	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—liver cancer	0.00024	0.00167	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—liver cancer	0.000238	0.00166	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—liver cancer	0.000237	0.00165	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—liver cancer	0.000236	0.00165	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—liver cancer	0.000236	0.00164	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—liver cancer	0.000233	0.00162	CcSEcCtD
Estropipate—Alopecia—Epirubicin—liver cancer	0.000231	0.00161	CcSEcCtD
Estropipate—Estradiol—CYP1A1—liver cancer	0.000231	0.0366	CrCbGaD
Estropipate—Mental disorder—Epirubicin—liver cancer	0.000229	0.0016	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—liver cancer	0.000229	0.00159	CcSEcCtD
Estropipate—Erythema—Epirubicin—liver cancer	0.000228	0.00159	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—liver cancer	0.000228	0.00159	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—liver cancer	0.000226	0.00158	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—liver cancer	0.000225	0.00156	CcSEcCtD
Estropipate—Flatulence—Epirubicin—liver cancer	0.000224	0.00156	CcSEcCtD
Estropipate—Tension—Epirubicin—liver cancer	0.000223	0.00156	CcSEcCtD
Estropipate—Nervousness—Epirubicin—liver cancer	0.000221	0.00154	CcSEcCtD
Estropipate—Back pain—Epirubicin—liver cancer	0.00022	0.00153	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—liver cancer	0.00022	0.00153	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—liver cancer	0.000219	0.00153	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—liver cancer	0.000219	0.00152	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—liver cancer	0.000218	0.00152	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—liver cancer	0.000214	0.00149	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—liver cancer	0.000212	0.00148	CcSEcCtD
Estropipate—Erythema—Doxorubicin—liver cancer	0.000211	0.00147	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—liver cancer	0.000211	0.00147	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—liver cancer	0.000208	0.00145	CcSEcCtD
Estropipate—Tension—Doxorubicin—liver cancer	0.000207	0.00144	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—liver cancer	0.000205	0.00143	CcSEcCtD
Estropipate—Vertigo—Epirubicin—liver cancer	0.000205	0.00143	CcSEcCtD
Estropipate—Back pain—Doxorubicin—liver cancer	0.000204	0.00142	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—liver cancer	0.000203	0.00141	CcSEcCtD
Estropipate—Palpitations—Epirubicin—liver cancer	0.000201	0.0014	CcSEcCtD
Estropipate—Cough—Epirubicin—liver cancer	0.000199	0.00138	CcSEcCtD
Estropipate—Myalgia—Epirubicin—liver cancer	0.000194	0.00135	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—liver cancer	0.000194	0.00135	CcSEcCtD
Estropipate—Anxiety—Epirubicin—liver cancer	0.000193	0.00135	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000193	0.00134	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—liver cancer	0.000189	0.00132	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—liver cancer	0.000186	0.0013	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—liver cancer	0.000186	0.00129	CcSEcCtD
Estropipate—Oedema—Epirubicin—liver cancer	0.000186	0.00129	CcSEcCtD
Estropipate—Infection—Epirubicin—liver cancer	0.000185	0.00129	CcSEcCtD
Estropipate—Cough—Doxorubicin—liver cancer	0.000184	0.00128	CcSEcCtD
Estropipate—Nervous system disorder—Epirubicin—liver cancer	0.000182	0.00127	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—liver cancer	0.000181	0.00126	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—liver cancer	0.000179	0.00125	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—liver cancer	0.000179	0.00125	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—liver cancer	0.000179	0.00125	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000178	0.00124	CcSEcCtD
Estropipate—Oedema—Doxorubicin—liver cancer	0.000172	0.0012	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—liver cancer	0.000172	0.0012	CcSEcCtD
Estropipate—Infection—Doxorubicin—liver cancer	0.000171	0.00119	CcSEcCtD
Estropipate—Estrone—ALB—liver cancer	0.00017	0.0269	CrCbGaD
Estropipate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000169	0.00118	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—liver cancer	0.000169	0.00117	CcSEcCtD
Estropipate—Insomnia—Epirubicin—liver cancer	0.000168	0.00117	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—liver cancer	0.000167	0.00116	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—liver cancer	0.000167	0.00116	CcSEcCtD
Estropipate—Somnolence—Epirubicin—liver cancer	0.000165	0.00115	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—liver cancer	0.000164	0.00114	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—liver cancer	0.00016	0.00112	CcSEcCtD
Estropipate—Fatigue—Epirubicin—liver cancer	0.00016	0.00112	CcSEcCtD
Estropipate—Pain—Epirubicin—liver cancer	0.000159	0.00111	CcSEcCtD
Estropipate—Constipation—Epirubicin—liver cancer	0.000159	0.00111	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000157	0.00109	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—liver cancer	0.000156	0.00108	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—liver cancer	0.000154	0.00108	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—liver cancer	0.000153	0.00106	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—liver cancer	0.000152	0.00106	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—liver cancer	0.000151	0.00105	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000148	0.00103	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—liver cancer	0.000148	0.00103	CcSEcCtD
Estropipate—Urticaria—Epirubicin—liver cancer	0.000148	0.00103	CcSEcCtD
Estropipate—Pain—Doxorubicin—liver cancer	0.000147	0.00102	CcSEcCtD
Estropipate—Constipation—Doxorubicin—liver cancer	0.000147	0.00102	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—liver cancer	0.000147	0.00102	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—liver cancer	0.000147	0.00102	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000141	0.00098	CcSEcCtD
Estropipate—Hypersensitivity—Epirubicin—liver cancer	0.000137	0.000954	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—liver cancer	0.000137	0.000952	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—liver cancer	0.000136	0.000947	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—liver cancer	0.000136	0.000947	CcSEcCtD
Estropipate—Asthenia—Epirubicin—liver cancer	0.000133	0.000929	CcSEcCtD
Estropipate—Pruritus—Epirubicin—liver cancer	0.000131	0.000916	CcSEcCtD
Estropipate—Estradiol—ALB—liver cancer	0.000128	0.0204	CrCbGaD
Estropipate—Diarrhoea—Epirubicin—liver cancer	0.000127	0.000886	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—liver cancer	0.000127	0.000883	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—liver cancer	0.000123	0.00086	CcSEcCtD
Estropipate—Dizziness—Epirubicin—liver cancer	0.000123	0.000856	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—liver cancer	0.000122	0.000848	CcSEcCtD
Estropipate—Vomiting—Epirubicin—liver cancer	0.000118	0.000823	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—liver cancer	0.000118	0.00082	CcSEcCtD
Estropipate—Rash—Epirubicin—liver cancer	0.000117	0.000816	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—liver cancer	0.000117	0.000816	CcSEcCtD
Estropipate—Headache—Epirubicin—liver cancer	0.000116	0.000811	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—liver cancer	0.000114	0.000792	CcSEcCtD
Estropipate—Nausea—Epirubicin—liver cancer	0.00011	0.000769	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—liver cancer	0.000109	0.000762	CcSEcCtD
Estropipate—Rash—Doxorubicin—liver cancer	0.000108	0.000755	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—liver cancer	0.000108	0.000755	CcSEcCtD
Estropipate—Headache—Doxorubicin—liver cancer	0.000108	0.00075	CcSEcCtD
Estropipate—Nausea—Doxorubicin—liver cancer	0.000102	0.000712	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.78e-05	0.000236	CbGpPWpGaD
Estropipate—ALB—Metabolism—CPT1B—liver cancer	2.76e-05	0.000235	CbGpPWpGaD
Estropipate—ALB—Metabolism—GLUL—liver cancer	2.76e-05	0.000235	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	2.75e-05	0.000233	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	2.74e-05	0.000232	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HGF—liver cancer	2.71e-05	0.00023	CbGpPWpGaD
Estropipate—ALB—Hemostasis—CSF2—liver cancer	2.68e-05	0.000228	CbGpPWpGaD
Estropipate—ALB—Metabolism—NR1H4—liver cancer	2.67e-05	0.000226	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HPGDS—liver cancer	2.66e-05	0.000226	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTA3—liver cancer	2.62e-05	0.000222	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.52e-05	0.000214	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—UGDH—liver cancer	2.46e-05	0.000209	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.45e-05	0.000208	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTA4—liver cancer	2.4e-05	0.000203	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PSMD10—liver cancer	2.37e-05	0.000201	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PSMA4—liver cancer	2.37e-05	0.000201	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.34e-05	0.000199	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.34e-05	0.000198	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ADAM17—liver cancer	2.34e-05	0.000198	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTA2—liver cancer	2.34e-05	0.000198	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EPT1—liver cancer	2.32e-05	0.000196	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GOT2—liver cancer	2.31e-05	0.000196	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—H2AFX—liver cancer	2.28e-05	0.000194	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	2.26e-05	0.000192	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GLUL—liver cancer	2.26e-05	0.000192	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CPT1B—liver cancer	2.26e-05	0.000192	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTA1—liver cancer	2.25e-05	0.000191	CbGpPWpGaD
Estropipate—ALB—Metabolism—NAT2—liver cancer	2.23e-05	0.000189	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PSMD10—liver cancer	2.2e-05	0.000187	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PSMA4—liver cancer	2.2e-05	0.000187	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TAT—liver cancer	2.2e-05	0.000186	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NR1H4—liver cancer	2.18e-05	0.000185	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK14—liver cancer	2.17e-05	0.000184	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP2E1—liver cancer	2.17e-05	0.000184	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.15e-05	0.000182	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTA3—liver cancer	2.15e-05	0.000182	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.14e-05	0.000182	CbGpPWpGaD
Estropipate—ALB—Metabolism—ALDOB—liver cancer	2.14e-05	0.000181	CbGpPWpGaD
Estropipate—ALB—Hemostasis—F2—liver cancer	2.11e-05	0.000179	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—liver cancer	2.1e-05	0.000178	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.09e-05	0.000178	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	2.05e-05	0.000174	CbGpPWpGaD
Estropipate—ALB—Metabolism—CRABP1—liver cancer	2.04e-05	0.000173	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.04e-05	0.000173	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARA—liver cancer	2.03e-05	0.000172	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYCS—liver cancer	2.03e-05	0.000172	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CG—liver cancer	2.02e-05	0.000171	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GGT1—liver cancer	1.99e-05	0.000169	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GOT1—liver cancer	1.99e-05	0.000169	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—liver cancer	1.99e-05	0.000169	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTA4—liver cancer	1.96e-05	0.000166	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CPT1B—liver cancer	1.93e-05	0.000164	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GLUL—liver cancer	1.93e-05	0.000164	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.92e-05	0.000163	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTA2—liver cancer	1.91e-05	0.000162	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—liver cancer	1.9e-05	0.000161	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK14—liver cancer	1.88e-05	0.000159	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NR1H4—liver cancer	1.86e-05	0.000158	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTA1—liver cancer	1.84e-05	0.000156	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.84e-05	0.000156	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTA3—liver cancer	1.83e-05	0.000156	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.83e-05	0.000155	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NAT2—liver cancer	1.82e-05	0.000155	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTP1—liver cancer	1.79e-05	0.000152	CbGpPWpGaD
Estropipate—ALB—Metabolism—HPGDS—liver cancer	1.78e-05	0.000151	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CD—liver cancer	1.77e-05	0.00015	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.77e-05	0.00015	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HMOX1—liver cancer	1.77e-05	0.00015	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.75e-05	0.000149	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SERPINE1—liver cancer	1.75e-05	0.000149	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALDOB—liver cancer	1.75e-05	0.000148	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PRKCE—liver cancer	1.7e-05	0.000145	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARG—liver cancer	1.68e-05	0.000142	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTA4—liver cancer	1.68e-05	0.000142	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CRABP1—liver cancer	1.67e-05	0.000142	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTM1—liver cancer	1.65e-05	0.00014	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.64e-05	0.000139	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTA2—liver cancer	1.63e-05	0.000139	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF2—liver cancer	1.61e-05	0.000137	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.61e-05	0.000137	CbGpPWpGaD
Estropipate—ALB—Metabolism—PSMA4—liver cancer	1.59e-05	0.000135	CbGpPWpGaD
Estropipate—ALB—Metabolism—PSMD10—liver cancer	1.59e-05	0.000135	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAF1—liver cancer	1.58e-05	0.000134	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTA1—liver cancer	1.58e-05	0.000134	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1A1—liver cancer	1.56e-05	0.000132	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NAT2—liver cancer	1.56e-05	0.000132	CbGpPWpGaD
Estropipate—ALB—Metabolism—GOT2—liver cancer	1.54e-05	0.000131	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CB—liver cancer	1.54e-05	0.000131	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SERPINE1—liver cancer	1.51e-05	0.000128	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CSF2—liver cancer	1.51e-05	0.000128	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.5e-05	0.000127	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.5e-05	0.000127	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALDOB—liver cancer	1.49e-05	0.000127	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GLUL—liver cancer	1.49e-05	0.000127	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CPT1B—liver cancer	1.49e-05	0.000127	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.49e-05	0.000127	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—H2AFX—liver cancer	1.49e-05	0.000126	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HPGDS—liver cancer	1.46e-05	0.000124	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—MTHFR—liver cancer	1.45e-05	0.000123	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP2E1—liver cancer	1.45e-05	0.000123	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.45e-05	0.000123	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NR1H4—liver cancer	1.44e-05	0.000122	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARA—liver cancer	1.43e-05	0.000121	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CRABP1—liver cancer	1.43e-05	0.000121	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—liver cancer	1.42e-05	0.00012	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA3—liver cancer	1.41e-05	0.00012	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.41e-05	0.000119	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.37e-05	0.000116	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYCS—liver cancer	1.36e-05	0.000115	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—liver cancer	1.34e-05	0.000114	CbGpPWpGaD
Estropipate—ALB—Metabolism—GGT1—liver cancer	1.33e-05	0.000113	CbGpPWpGaD
Estropipate—ALB—Metabolism—GOT1—liver cancer	1.33e-05	0.000113	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.32e-05	0.000112	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—liver cancer	1.32e-05	0.000112	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.3e-05	0.000111	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PSMA4—liver cancer	1.3e-05	0.00011	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PSMD10—liver cancer	1.3e-05	0.00011	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA4—liver cancer	1.29e-05	0.00011	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.28e-05	0.000109	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GOT2—liver cancer	1.26e-05	0.000107	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA2—liver cancer	1.26e-05	0.000107	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HPGDS—liver cancer	1.25e-05	0.000106	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.24e-05	0.000105	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KDR—liver cancer	1.23e-05	0.000104	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CG—liver cancer	1.22e-05	0.000104	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK14—liver cancer	1.22e-05	0.000104	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA1—liver cancer	1.22e-05	0.000103	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—liver cancer	1.21e-05	0.000102	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NAT2—liver cancer	1.2e-05	0.000102	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—liver cancer	1.2e-05	0.000102	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP2E1—liver cancer	1.19e-05	0.000101	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—F2—liver cancer	1.18e-05	0.0001	CbGpPWpGaD
Estropipate—ALB—Metabolism—HMOX1—liver cancer	1.18e-05	0.0001	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARG—liver cancer	1.18e-05	0.0001	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALDOB—liver cancer	1.15e-05	9.78e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.15e-05	9.76e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.13e-05	9.6e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—liver cancer	1.13e-05	9.6e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.13e-05	9.57e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.11e-05	9.45e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYCS—liver cancer	1.11e-05	9.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PSMA4—liver cancer	1.11e-05	9.42e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PSMD10—liver cancer	1.11e-05	9.42e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB1—liver cancer	1.11e-05	9.39e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—liver cancer	1.1e-05	9.34e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CRABP1—liver cancer	1.1e-05	9.33e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GGT1—liver cancer	1.09e-05	9.26e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GOT1—liver cancer	1.09e-05	9.26e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GOT2—liver cancer	1.08e-05	9.17e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CD—liver cancer	1.07e-05	9.11e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—liver cancer	1.06e-05	9.02e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—liver cancer	1.06e-05	8.99e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A1—liver cancer	1.04e-05	8.85e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—liver cancer	1.02e-05	8.69e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2E1—liver cancer	1.02e-05	8.62e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CD—liver cancer	9.95e-06	8.44e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SERPINE1—liver cancer	9.84e-06	8.35e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.84e-06	8.34e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—liver cancer	9.8e-06	8.32e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—MTHFR—liver cancer	9.73e-06	8.25e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HMOX1—liver cancer	9.67e-06	8.2e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HPGDS—liver cancer	9.62e-06	8.16e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—liver cancer	9.58e-06	8.12e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARA—liver cancer	9.54e-06	8.1e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYCS—liver cancer	9.5e-06	8.06e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—liver cancer	9.42e-06	7.99e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CB—liver cancer	9.36e-06	7.94e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GGT1—liver cancer	9.33e-06	7.91e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GOT1—liver cancer	9.33e-06	7.91e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—liver cancer	9.11e-06	7.73e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—liver cancer	9.01e-06	7.64e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAF1—liver cancer	8.88e-06	7.53e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—liver cancer	8.71e-06	7.39e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MTOR—liver cancer	8.67e-06	7.36e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CB—liver cancer	8.67e-06	7.36e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.57e-06	7.27e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PSMA4—liver cancer	8.57e-06	7.27e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PSMD10—liver cancer	8.57e-06	7.27e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A1—liver cancer	8.54e-06	7.24e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—liver cancer	8.38e-06	7.11e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GOT2—liver cancer	8.34e-06	7.07e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HMOX1—liver cancer	8.26e-06	7.01e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CG—liver cancer	8.17e-06	6.93e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—liver cancer	8.14e-06	6.9e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—liver cancer	7.98e-06	6.77e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—liver cancer	7.96e-06	6.76e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTHFR—liver cancer	7.96e-06	6.75e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARG—liver cancer	7.89e-06	6.69e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2E1—liver cancer	7.84e-06	6.65e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARA—liver cancer	7.81e-06	6.63e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—liver cancer	7.76e-06	6.59e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—liver cancer	7.75e-06	6.57e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—liver cancer	7.7e-06	6.53e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—liver cancer	7.69e-06	6.52e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—liver cancer	7.69e-06	6.52e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—liver cancer	7.54e-06	6.39e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—liver cancer	7.51e-06	6.37e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYCS—liver cancer	7.34e-06	6.22e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK8—liver cancer	7.33e-06	6.22e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1A1—liver cancer	7.3e-06	6.19e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GGT1—liver cancer	7.2e-06	6.11e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GOT1—liver cancer	7.2e-06	6.11e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CD—liver cancer	7.18e-06	6.09e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.02e-06	5.95e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTHFR—liver cancer	6.8e-06	5.77e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—liver cancer	6.77e-06	5.74e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—liver cancer	6.7e-06	5.68e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CG—liver cancer	6.69e-06	5.67e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARA—liver cancer	6.68e-06	5.66e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—liver cancer	6.64e-06	5.63e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—liver cancer	6.47e-06	5.48e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARG—liver cancer	6.46e-06	5.48e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HMOX1—liver cancer	6.38e-06	5.41e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CB—liver cancer	6.26e-06	5.31e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—liver cancer	6.23e-06	5.28e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFB1—liver cancer	6.21e-06	5.27e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6e-06	5.09e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—liver cancer	5.94e-06	5.04e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CD—liver cancer	5.88e-06	4.99e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—liver cancer	5.81e-06	4.92e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—liver cancer	5.75e-06	4.88e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CG—liver cancer	5.72e-06	4.85e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—liver cancer	5.71e-06	4.84e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A1—liver cancer	5.63e-06	4.78e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARG—liver cancer	5.52e-06	4.68e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—liver cancer	5.29e-06	4.48e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTHFR—liver cancer	5.25e-06	4.45e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARA—liver cancer	5.15e-06	4.37e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CB—liver cancer	5.13e-06	4.35e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—liver cancer	5.11e-06	4.34e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CD—liver cancer	5.03e-06	4.26e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—liver cancer	4.96e-06	4.21e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—liver cancer	4.89e-06	4.15e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—liver cancer	4.68e-06	3.97e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—liver cancer	4.66e-06	3.95e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CG—liver cancer	4.41e-06	3.74e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CB—liver cancer	4.38e-06	3.72e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—liver cancer	4.32e-06	3.66e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARG—liver cancer	4.26e-06	3.61e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CD—liver cancer	3.88e-06	3.29e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—liver cancer	3.83e-06	3.25e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—liver cancer	3.82e-06	3.24e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CB—liver cancer	3.38e-06	2.87e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—liver cancer	3.12e-06	2.65e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—liver cancer	3.12e-06	2.65e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—liver cancer	2.67e-06	2.27e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—liver cancer	2.55e-06	2.17e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—liver cancer	2.18e-06	1.85e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—liver cancer	2.06e-06	1.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—liver cancer	1.68e-06	1.43e-05	CbGpPWpGaD
